Japan Lifeline Co., Ltd. (the Company) announced that at the Board of Directors meeting held today, it has resolved to acquire shares of Synexmed(Shenzhen) Co., Ltd., a wholly owned subsidiary of Synexmed(Hong Kong) Limited, which is a wholly owned subsidiary of the Company.
1. Reason for the Share Acquisition
Synexmed(Shenzhen) Co., Ltd. is a Company's overseas manufacturing base for its proprietary products, and the purpose of this share acquisition is to improve the efficiency of the management of the corporate group as a whole by directly holding the shares of the said company.
2. Outline of the Acquired Company
1.
Company Name
Synexmed(Shenzchen) Co., Ltd.
2.
Location
Shenzchen, Guangdong Province, China
3.
Representative Officer
Shogo Takahashi (Chairman)
4.
Business Description
Manufacturing and sales of medical devices
5.
Capital
2.5 million USD (279 million JPY）*1
6.
Date of Establishment
March 30, 2005
7.
Major Shareholders and their
Synexmed(Hong Kong) Limited：100%
Shareholding Ratio
Capital
The Company indirectly owns 100% of the shares of
Relationship
this company.
8.
Relationship with the
Personal
Two officers of the Company concurrently serve as
Company
Relationship
officers of the said company.
Business
The Company indirectly receives supply of products
Relationship
from the said company.
*1 The yen conversion rate of the capital is based on the foreign exchange rate for customers provided by MUFG Bank, Ltd. as of September 29, 2021 (1 USD = 111.65JPY (TTM)) (Figures are rounded down to the nearest million yen)
1
3. Outline of the counterparty to the share acquisition
1.
Company Name
Synexmed(Hong Kong) Limited
2.
Location
Hong Kong
3.
Representative Officer
Shogo Takahashi (Managing Director)
4.
Business Description
Import and sales of medical devices
5.
Capital
15 million Hong Kong dollars (218 million JPY)※2
6.
Date of Establishment
December 17, 2004
7.
Major Shareholder and their
Japan Lifeline Co., Ltd：100%
Shareholding Ratio
Capital
The Company owns 100% of the shares of this
Relationship
company.
8.
Relationship with the
Personal
Two officers of the Company concurrently serve as
Company
Relationship
officers of the said company.
Business
The Company receives supply of products from the
Relationship
said company.
*2 The yen conversion rate of the capital is based on the foreign exchange rate for customers provided by MUFG Bank, Ltd. as of September 29, 2021 (1 HKD = 14.34 JPY (TTM)) (Figures are rounded down to the nearest million yen)
4. Schedule
1.
Resolution by the Board of
September 30, 2021
Directors
2.
Date of Conclusion of Share
September 30, 2021
Transfer Agreement
3.
Execution Date of Share
October 8, 2021(Scheduled)
Transfer
5. Impact on Business Result
As this share acquisition is an intra-group transaction, the impact on the Company's consolidated business results will be minimal.
2
Attachments
Original document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on 30 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 September 2021 06:11:10 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
